BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ACell, Inc. Launches National Physician Education Initiative


7/9/2013 9:49:34 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

COLUMBIA, Md., July 9, 2013 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development and commercialization of unique extracellular matrix products, announced today the launch of a national physician education initiative consisting of educational courses, hands-on training, and peer-to-peer events.

The Company is offering a series of educational courses for physicians to advance their knowledge of regenerative medicine and surgical techniques using the MatriStem extracellular matrix for a variety of indications, including hernia/abdominal wall repair, pelvic floor reconstruction, general surgery, wound care and other indications.

The hands-on sessions include surgical training at multiple locations across the U.S. presented by thought-leading surgeons. Upcoming courses will focus on hernia/abdominal wall repair, reconstructive surgery and pelvic floor repair.

ACell has also established a Speakers' Bureau of experts in regenerative medicine. These thought-leading surgeons will present at local and regional physician peer-to-peer events, and via webinars, to highlight positive clinical outcomes they have achieved using ACell's MatriStem extracellular matrix.

"MatriStem represents a true leap forward in our ability to treat patients in a variety of situations that previously would have been difficult to treat," said Speaker's Bureau member John Zografakis, M.D. of Akron, Ohio. "The regenerative properties of MatriStem encourage the constructive remodeling of tissue with a unique healing response in both routine and very extraordinary clinical situations."

Rodney Bosley, ACell President & COO, said, "The launch of this national physician training program is a major step to further expand the use of MatriStem and drive our continued growth. Physicians continue to recognize the unique healing and constructive tissue remodeling characteristics of MatriStem and use it in a wide range of applications. This education initiative is designed to leverage the clinical community's broad experience with MatriStem to expand awareness and understanding of how it can be used to achieve improved outcomes in both surgical and wound care applications."

About ACell

ACell, Inc. is a leading developer, manufacturer and marketer of next-generation regenerative medicine products. Its products are cleared for a variety of indications and are marketed under the brand name "MatriStem." A privately held company, ACell produces MatriStem in its manufacturing facilities and markets its products to physicians in the U.S. through a national direct sales force. For more information, call (800) 826-2926 or visit www.acell.com.

About MatriStem

MatriStem Products consist of porcine-derived extracellular matrix (ECM) that maintain and support a healing environment through constructive remodeling, and are available in particle and sheet forms by prescription only. These devices, trademarked as MatriStem, are appropriate for acute wounds, chronic wounds and various surgical procedures. All MatriStem devices are made in the USA. Refer to IFU supplied with each device for indications, contraindications, and precautions.

Contacts:

Jon Werner
Director of Marketing
(410) 715-1700

Lisa Cook (media)
The Ruth Group
646-536-7012
lcook@theruthgroup.com

SOURCE ACell, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES